Noticiero farmacológico: Pharmacologic news

Patricia Cardoso; Raul Plager

Autores/as

Patricia Cardoso Médica de planta de la Unidad de Toxicología
Raul Plager Consultor Toxicológico del Hospital Materno Infantil de San Isidro

Palabras clave:

Acetazolamida, Topiramato, Lamotrigina, Paroxetina, Ataluren

Resumen

Sección a Cargo de Patricia Cardoso y Rau?l Plager

Acetazolamida: notificación de casos de efusión coroidea / desprendimiento coroideo
Lamotrigina: síndrome de Stevens Johnson y Necrólisis epidérmica tóxica en pacientes de origen asiático con alelo HLA-B*1502
Lamotrigina: tics (motores y vocales)
Lamotrigina: uso de terapia lipídica ante cardiotoxicidad por sobredosis
Topiramato: recomendaciones para evitar la exposición durante el embarazo
Paroxetina: leucopenia
Ataluren: reexaminación de la Agencia Europea de Medicamentos

Citas

https://www.ema.europa.eu/en/documents/prac-recommendation/prac-recommendations-signals-adopted-28-31-august-2023-prac-meeting_en.pdf

https://www.ema.europa.eu/en/documents/psusa/lamotrigine-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable/00001825/202211_es.pdf

Touafchia D, Montastruc F, Lapeyre-Mestre M, et al. Drug-induced tics: An observational postmarketing study. Hum Psychopharmacol. 2020; 35(4):e2734.

https://www.ema.europa.eu/en/documents/psusa/lamotrigine-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable/00001825/202211_es.pdf

Bjørk M, Zoega H, Leinonen MK, et al. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol. 2022; 79(7):672-681. doi: 10.1001/jamaneurol.2022.1269.

Dreier JW, Bjørk M, Alvestad S, et al. Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. JAMA Neurol. 2023; 80(6):568-577. doi: 10.1001/jamaneurol.2023.0674.

Hernandez-Diaz S, Straub L, Bateman B, et al. Topiramate During Pregnancy and the Risk of Neurodevelopmental Disorders in Children. In: ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022. Pharmacoepidemiol Drug Saf, 2022; 31 Suppl 2:3-678, abstract 47.

https://www.ema.europa.eu/en/documents/psusa/paroxetine-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable/00002319/202212_en.pdf

https://www.ema.europa.eu/en/news/ema-recommends-non-renewal-authorisation-duchenne-muscular-dystrophy-medicine-translarna